Trial NCT04244591
Publication Steroids-SARI - Du, Unpublished (2020) ( )
Funding: Public/non profit (Peking Union Medical College Hospital, Zhongda Hospital, Zhongnan Hospital, Renmin Hospital of Wuhan University)
Conflict of interest: *
Methods | |
RCT Blinding: Unblinded | |
Location :
Multicenter / China Follow-up duration (days): 30 | |
Inclusion criteria |
|
Exclusion criteria |
|
Interventions | |
Treatment
Methylprednisolone |
|
Control
Standard care | |
Participants | |
Randomized participants : Methylprednisolone=24 Standard care=23 | |
Characteristics of participants N= 47 Mean age : NR 35 males Severity : Mild: n=0 / Moderate: n=0 / Severe: n=20 Critical: n=27 Number of vaccinated participants: NR | |
Primary outcome | |
In the register Lower Murray lung injury score [ Time Frame: 7 days after randomization ], Lower Murray lung injury score [ Time Frame: 14 days after randomization ] | |
In the report NR | |
Documents available |
Protocol NR Statistical plan NR Data-sharing willing stated in the publication:
|
Risk of bias Overall The overall risk of bias reported in the table corresponds to the highest risk of bias for the outcomes assessed for the systematic review |
Some concerns |
General comment | The study is not published yet. Data presented was extracted from study registry, and Sterne, Jonathan AC, et al. "Association between Administration of Systemic Corticosteroids and Mortality among critically ill patients with COVID-19: a meta-analysis." Jama (2020). The authors have been contacted in order to obtain the results. |